Galectin Therapeutics
Manufacturing · Georgia, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
4960 Peachtree Industrial Blvd Ste 240, ...Phone Number
(678) 620-3186Website
www.galectintherapeutics.comRevenue
$37.4 MillionStock Symbol
GALTIndustry
About Galectin Therapeutics
Galectin Therapeutics develops innovative therapies aimed at improving the lives of patients suffering from chronic liver diseases, particularly Metabolic Dysfunction-Associated Steatohepatitis (MASH) cirrhosis, and cancer. Their lead product, belapectin (GR-MD-02), is a galectin-3 inhibitor that targets various inflammatory, fibrotic, and malignant diseases. The company is focused on advancing clinical studies, including the NAVIGATE study for MASH cirrhosis, to provide new treatment options where none currently exist. Galectin Therapeutics is dedicated to addressing the urgent medical needs of patients facing life-threatening conditions related to liver health and cancer.Explore more
SIC Code 28,283NAICS Code 32,325Ticker NASDAQ: GALTShow moreGalectin Therapeutics Org Chart
Compare Similar Companies to Galectin Therapeutics
Compare insights from companies similar to Galectin Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Galectin Therapeutics Tech Stack
A closer look at the technologies used by Galectin Therapeutics
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Galectin Therapeutics
Sign Up For FreeTo access detailed company insights
Galectin Therapeutics develops innovative therapies aimed at improving the lives of patients suffering from chronic liver diseases, particularly Metabolic Dysfunction-Associated Steatohepatitis (MASH) cirrhosis, and cancer. Their lead product, belapectin (GR-MD-02), is a galectin-3 inhibitor that targets various inflammatory, fibrotic, and malignan... Read More